17:45 - 19:00
Poster viewing
Room: Galeries and Marie Curie
Chair/s:
Adriana Fernandez, Dana Boctor
TEDUGLUTIDE INCREASES ADAPTATION IN A MURINE SHORT BOWEL MODEL BY IMPROVING EPITHELIAL TIGHT JUNCTION SELECTIVITY
Johannes Reiner 1, Jakob Wobar 1, Robert Jaster 1, Ernst Klar 2, Brigitte Vollmar 3, Maria Witte 2, Georg Lamprecht 1, Peggy Berlin 1
1 University Medical Center Rostock, Department of Medicine II, Division of Gastroenterology
2 University Medical Center Rostock, Department of General, Thoracic, Vascular and Transplantation Surgery
3 University Medical Center Rostock, Institute of Experimental Surgery

Introduction: Teduglutide is used in chronic intestinal failure in order to reduce the need for and to increase time off parenteral nutrition. A trophic effect is induced through GLP-2 stimulation resulting in an improved uptake of water and sodium. It is unclear if the Claudin-10 and -15 mediated sodium selectivity of the paracellular tight junction in the jejunum is influenced. Thus, the effects of Teduglutide were studied in a murine short bowel model.

Methods: By resecting 40 % of the Ileocecal region (ICR) a severe murine short bowel syndrome was simulated. Subcutaneous Teduglutide (0.1 mg/kg BW) or vehicle administration began 36 h postperatively. Survival, development of body weight, stool consistency, plasma aldosterone levels, tight junction protein expression, FITC-4kDa-Dextran-Flux and dilution potentials using an Ussing chamber were analyzed.

Results: Compared to vehicle, the development of body weight in Teduglutide treated animals was more favourable (weight nadir vehicle: 83,6 ± 1,4 % n=15 vs. Teduglutide 87,8 ± 1,4 % n=12, p<0.05). Lower aldosterone levels in Teduglutide treated animals indicated a better volume state in this group (vehicle 988 ± 172 ng/l, n=6 vs. Teduglutide: 512 ± 91.5 ng/l, n=9-11, p<0.05). The transmucosal barrier for macromolecules in the jejunum in short bowel conditions increased independently of Teduglutide administration. Occludin and Claudin-15 mRNA expression was increased after ICR, independent of Teduglutide treatment. In the jejunum of vehicle treated animals, cation permselectivity was impaired. At the same time, Claudin-10 mRNA expression in vehicle treated mice was reduced to 55.2 ± 8.5% of baseline, while it was maintained in Teduglutide treated animals at 109 ± 23.7%, n=3-4, p<0.05. In line with this, tight junction localization of Claudin-10 faded towards the villus tips in vehicle treated mice while permselectivity and Claudin-10 expression up to the villus tip remained constant in Teduglutide treated animals.

Conclusion: Teduglutide alleviates intestinal insufficiency in this mouse model of short bowel syndrome. Teduglutide not only induces trophic effects but retains epithelial function by maintaining Claudin-10 expression. This translates to improved paracellular cation permeability, facilitating sodium recirculation and thus sodium coupled nutrient transport, leading to improved nutrition status.


Session:
POSTER OF DISTINCTION - Poster Viewing with a Wine & Cheese buffet
Presenter/s:
Johannes Reiner
Presentation type:
Poster only presentation
Room:
Galeries and Marie Curie
Chair/s:
Adriana Fernandez, Dana Boctor
Date:
Thursday, July 4, 2019
Time:
17:45 - 19:00
Session times:
17:45 - 19:00